Tolerability of Antihypertensive Medications in Older Adults
- PMID: 26442857
- DOI: 10.1007/s40266-015-0296-3
Tolerability of Antihypertensive Medications in Older Adults
Abstract
Several guidelines for hypertension have recently undergone revisions to incorporate an approach providing choices of medications based on age, race, and specific situations where hypertension may co-exist with disorders such as diabetes, coronary artery disease, heart failure and chronic kidney disease. Initial recommendations include diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers; beta blockers are favored in some guidelines and are a choice in specific settings. Within the classes of drugs, several antihypertensive agents provide options. This review discusses antihypertensive drugs by class, including adverse effects and tolerability, with preferences in older adults and specific settings. Adverse drug events from antihypertensive medications are discussed by class and where applicable for specific agents. Data from select studies pertinent to tolerability and adverse effects are presented in tables for several classes of drugs. The rationale for nonadherence to medication is reviewed, including the roles played by tolerability and adverse drug effects. Antihypertensive therapy in typical settings in older adults is discussed; they include hypertension in association with impaired cognition, depression, diabetes, sexual dysfunction, and falls. The key to successful therapy and tolerability is to promote a healthy lifestyle in conjunction with medications as the approach, thereby also lowering the adverse drug effects. The eventual choice of the specific drug(s) is based on risks, benefits, and patient preferences, and is best tailored for each older adult.
Similar articles
-
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004. Drugs Aging. 2006. PMID: 16536636 Review.
-
Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.Drugs Aging. 2017 Jun;34(6):453-466. doi: 10.1007/s40266-017-0452-z. Drugs Aging. 2017. PMID: 28432600
-
Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.J Hypertens. 2016 Oct;34(10):1921-32. doi: 10.1097/HJH.0000000000001052. J Hypertens. 2016. PMID: 27454050 Review.
-
Association between cardiovascular outcomes and antihypertensive drug treatment in older women.JAMA. 2004 Dec 15;292(23):2849-59. doi: 10.1001/jama.292.23.2849. JAMA. 2004. PMID: 15598916
-
Clinical overview of antihypertensive classes--clinically relevant differences: myths or facts? Based on a presentation by Alan H. Gradman, MD.Am J Manag Care. 2000 Mar;6(4 Suppl):S197-210. Am J Manag Care. 2000. PMID: 10977460 Review.
Cited by
-
Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.BMJ Open. 2017 Sep 21;7(9):e015877. doi: 10.1136/bmjopen-2017-015877. BMJ Open. 2017. PMID: 28939571 Free PMC article.
-
Correlation of polypill and blood pressure level: A systematic review of clinical trials.J Educ Health Promot. 2023 May 31;12:171. doi: 10.4103/jehp.jehp_845_22. eCollection 2023. J Educ Health Promot. 2023. PMID: 37404929 Free PMC article.
-
Adverse Drug Events in Patients with Dementia and Neuropsychiatric/Behavioral, and Psychological Symptoms, a One-Year Prospective Study.Int J Environ Res Public Health. 2019 Mar 15;16(6):934. doi: 10.3390/ijerph16060934. Int J Environ Res Public Health. 2019. PMID: 30875907 Free PMC article.
-
High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17.Korean J Physiol Pharmacol. 2017 Jan;21(1):99-106. doi: 10.4196/kjpp.2017.21.1.99. Epub 2016 Dec 21. Korean J Physiol Pharmacol. 2017. PMID: 28066146 Free PMC article.
-
Chronic Intermittent Hypobaric Hypoxia Ameliorates Renal Vascular Hypertension Through Up-regulating NOS in Nucleus Tractus Solitarii.Neurosci Bull. 2019 Feb;35(1):79-90. doi: 10.1007/s12264-018-00330-z. Epub 2019 Jan 7. Neurosci Bull. 2019. PMID: 30617765 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical